Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Open-Label Safety Study of ADS-5102 in PD Patients With LID [Phase 3]
Open-label safety study of ADS-5102 in Parkinson's disease patients with levodopa-induced dyskinesia completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating the feasibility and acceptability of a physical activity behavior change intervention for Parkinson's disease; co…
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations [Phase 2]
Phase 2 clinical trial updates for KW-6356 in Parkinson's disease patients on levodopa therapy have been completed.
-
FDA approval · 2020-08-31FDA Approved: INBRIJA — Supplemental Application (Merz Pharmaceuticals, LLC)
FDA approved a supplemental application for INBRIJA (levodopa) submitted by Merz Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression [Phase 2]
Phase 2 trial evaluating pimavanserin for depression in adults with Parkinson's disease; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy [Phase 2]
Phase 2 clinical trial update for KW-6500 in Parkinson's disease patients with motor response complications on levodopa therapy.
-
FDA approval · 2020-08-26FDA Approved: ROPINIROLE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for ropinirole from Accord Healthcare Inc. under an ANDA. This confirms continued availability o…
-
FDA approval · 2020-08-21FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Bromocriptine Mesylate submitted by Padagis US LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER) [Phase 3]
Phase 3 trial comparing Levodopa-Carbidopa intestinal gel/Carbidopa-Levodopa enteral suspension to optimized medical therapy in advanced Par…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease [Phase 2]
Phase 2 clinical trial assessing the effectiveness of Botulinum toxin (Botox) to reduce rest tremor in Parkinson's disease has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes [Phase 2]
Phase 2 trial comparing systemic exposure of apomorphine from an investigational apomorphine-containing drug versus subcutaneous apomorphine…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal [Phase 2]
A Phase 2 clinical trial exploring intranasal levodopa for Parkinson's Disease has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study [Phase 1, Phase 2]
Clinical trial update on safety of CDNF via brain infusion in Parkinson's disease, extending the HP-CD-CL-2002 study; completed Phase 1/2.
-
CLINICAL_TRIALS research · 2020-08-10Clinical Trial Update: A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes [Phase 2]
Phase 2 cardiac safety study evaluating an investigational drug in people with Parkinson's disease experiencing motor fluctuations during
-
FDA approval · 2020-08-06FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ropinirole submitted by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease [Phase 2, Phase 3]
A completed Phase 2/Phase 3 study evaluating fecal microbiota transplantation as a potential treatment for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Melatonin on Clock Genes in Parkinson's Disease [Phase 2, Phase 3]
A clinical trial investigating melatonin effects on clock genes in Parkinson's disease has been withdrawn after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease [Phase 3]
Phase 3 trial evaluating APL-130277 for acute treatment of OFF episodes in Parkinson's disease completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: A Study to Examine APL-130277 in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial update for APL-130277 in Parkinson's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Dopaminergic Loss and Pain in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update examining dopaminergic loss and pain in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Study of Urate Elevation in Parkinson's Disease, Phase 3 [Phase 3]
Phase 3 clinical trial evaluating urate elevation in Parkinson's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Nilotinib in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating nilotinib in Parkinson's disease has completed and results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Tolerance to NeuroEPO in Parkinson Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating tolerance to NeuroEPO in patients with Parkinson disease has been completed.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease [NA]
A completed clinical trial evaluating the impact of endurance exercise on cognitive and motor outcomes in Parkinson's disease patients with …
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Cognitive Decline in Non-demented PD [Phase 4]
Phase 4 clinical trial update on cognitive decline in non-demented Parkinson's disease patients; results posted.